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I. INTRODUCTION
Doping in sports goes back thousands of years to the ancient Olympic
Games in Greece where athletes tried to improve their performance through
artificial means.1 However, as the effects and long-term consequences of
doping have been revealed, and issues surrounding fairness and ethics have
come to the forefront, more organizations have sought to detect and control
doping by athletes.
The attempts to detect doping have come from the scientific community in
the form of detection tests. The legal community attempts to control doping in
the form of laws banning certain substances. However, there are others in the
scientific community continuously searching for new methods of doping and
new, non-detectable drugs, while the legal community is limited by personal
rights regarding privacy and limits on what tests are legally valid, which
prevent the laws from always keeping up with the science. The legal
community is continually trying to keep up with this constant clash between
those that attempt to develop new means of doping and those that attempt to
detect it. This article will examine how some physiological obstacles to
accurate drug testing are compounded by the legal obstacles involving whether
such drug testing is even admissible in a court of law.
This article is divided into two main sections. Section II discusses the
physiological barriers to accurate drug testing. The topics covered include the
* Ph.D. student in Sport Administration, University of New Mexico; M.S. 2006, New York
University; J.D. 2004, Marquette University Law School; B.A. 2001, University of Wisconsin-
Madison.
** Ph.D. student in Exercise Physiology, University of New Mexico; M.S. 2001, University of
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1. Kenneth D. Fitch, Androgenic-Anabolic Steroids and the Olympic Games, 10 ASIAN J.
ANDROL. 384, 384 (2008).
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types of tests used to detect doping and some specific types of ergogenic aids
and the problems that arise when trying to detect them. Section III examines
the legal obstacles that exist, including constitutional concerns and to whom
the Constitution applies, as well as issues surrounding the admissibility of
scientific evidence in court. Section IV concludes with a brief discussion of
the consequences of inaccurate drug testing.
II. PHYSIOLOGICAL BARRIERS
Modem drug testing began in the late 1950s, with the death of elite
cyclists, occuring in the 1960s from amphetamine use. 2 "The first formal
testing for non-steroidal drugs occurred at the 1972... Olympics Games" in
Munich, Germany. 3 With the addition of radioimmunoassay (RIA) and gas
chromatography-mass spectrometry (GC-MS) methods, anabolic steroids were
tested for in the 1976 Montreal Olympic Games. 4 In 1983, there was a test
developed for detecting synthetic testosterone (T) by measuring urine T levels
and its chemical variation epitestosterone (E). 5 Although there are a variety of
tests used to detect doping, there are three tests for urine samples and two for
blood samples that are the primary tests discussed in this article.
A. Types of Drug Tests
The classes of drugs include, but are not limited to, stimulants, narcotics,
anabolic-androgenic steroids, beta-agonists, beta blockers, diuretics, peptide
hormones, and masking agents. 6 Due to the sheer number of ergogenic aids
available, this paper is limited to androgens, such as testosterone; beta2 -
agonists (132-agonists), like clenbuterol; and peptide hormones, such as human
growth hormone (hGH) and erythropoietin (EPO).
1. Gas Chromatography-Mass Spectrometry
All substances used in doping have unique "fingerprints," a specific
breakdown of the molecules of the substance into ionic pieces.7  Gas
Chromatography-Mass Spectrometry (GC-MS) isolates this fingerprint by
2. Craig R. Kammerer, What is Doping and How is it Detected, in DOPING IN ELITE SPORT: THE
POLITICS OF DRUGS IN THE OLYMPIC MOVEMENT 3, 4 (Wayne Wilson & Edward Derse eds., 2001).
3. Id.
4. Id.
5. Id.
6. Id. at 6.
7. Id. at 9.
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separating the suspected drugs from the other substances in the urine sample. 8
The suspected drugs are "then bombarded by small particles, causing
disintegration of the drug molecule into smaller fragments." 9  Computer
analysis determines what drug the substance is based on its fragmentation
pattern. '0 When performed properly, GC-MS has a near one hundred percent
accuracy and can test samples at very low concentrations. 11 The limitation, of
course, is that if there is no reference sample for a substance, it cannot be
tested for.
2. Liquid Chromatography-Mass Spectrometry
Liquid Chromatography-Mass Spectrometry (LC-MS) is similar to GC-
MS. 12 The only difference is that the sample is processed in a liquid state,
instead of a gaseous state. 13 The advantages of LC-MS over GC-MS is that
LC-MS can be performed at room temperature, unlike GC-MS, which requires
that the sample be heated until it turns into a gas. 14 LC-MS can also be used
to detect some substances GC-MS cannot, such as "unstable, polar, and large
molecular weight natural hormones ([h]GH, EPO, etc.)."' 15
3. Isotope Ratio Mass Spectrometry
The newest of the three tests discussed is Isotope Ratio Mass
Spectrometry (IRMS). This test is more specific in its purpose, being used
primarily to detect whether T levels are due to endogenous (within the body)
production or due to exogenous (outside the body) administration. 16 This test
looks for 13C, a carbon isotope that is affected by the amount of carbon
ingested.1 7 Since most synthetic T is made from soybeans, and soybeans have
a lower '3C content than natural T, those with an abnormally low 13C ratio are
considered to have used synthetic T. 18
8. David J. Greenblatt, Urine Drug Testing: What Does it Test?, 23 NEW ENG. L. REv. 651, 655
(1989).
9. Id.
10. Id.
11. Id.
12. Kammerer, supra note 2, at 9.
13. Id.
14. Id.
15. Id.
16. Id. at 10; Michael R. Graham et al., Anabolic Steroid Use: Patterns of Use and Detection of
Doping, 38 SPORTS MED. 505, 519 (2008).
17. Graham et al., supra note 16, at 519.
18. Id.
2008]
MARQUETTE SPORTS LA W REVIEW
The disadvantage of IRMS is that the instruments are very expensive, over
$100,000 each, and it cannot be used to screen for other routine drugs, such as
steroids. 19 IRMS also has difficulty distinguishing gender and metabolism
differences.
20
4. The Isoform Approach and the hGH-Responsive Proteins Method
There are two current methods for detecting hGH doping. Both are blood
tests, not urine tests. They are discussed in more detail in II.D. 1., the section
on human growth hormone.
B. Androgens
Over the past five decades, androgenic-anabolic steroids (AAS) have been
one of the drugs most abused by athletes to increase sports performance. AAS
are derivatives of testosterone that produce masculinizing (i.e. androgenic) and
tissue-building (anabolic) effects. 2 1 Although there is speculation that AAS
were used as early as the Olympic Games in the 1950s, there is evidence that
they were used at the Olympic Games in the 1960s, with more prevalence at
the 1972 Munich Olympics. 22 With the introduction of RIA in 1974, the
International Olympic Committee (IOC) "prohibited AAS with the first
positives at the 1976 Montreal Games." 23 The 1984 Olympic Games was the
first to use GC-MS to identify AAS. 24 Positives were found at the 1984
Olympics, and again in 1988 in Seoul, South Korea, where the 100-meter
sprint gold medal winner, Ben Johnson, tested positive for AAS use.25 There
are many different types of AAS, but one particular trouble area is the
detection of natural androgens: testosterone (T), epitestosterone (E), and
dihydrotestosterone (DHT).
1. Testosterone
The use of natural androgens is one way athletes have been able to avoid
detection. 26 Detecting prohibited use of natural androgens like T is difficult
19. Kammerer, supra note 2, at 10-11.
20. Id. at 11.
21. STAN REENTS, SPORT AND EXERCISE PHARMACOLOGY 162 (2000).
22. Fitch, supra note 1, at 385.
23. Id. at 386.
24. Id. at 387.
25. SHAUN ASSAEL, STEROID NATION xvi (ESPN Books 2007).
26. David J. Handelsman & Alison Heather, Androgen Abuse in Sports, 10 ASIAN J. ANDROL.
403, 405 (2008).
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because it "requires distinguishing between endogenous and exogenous forms
of the same steroid" molecule. 27 The testosterone/epitestosterone ratio (T/E
ratio) test is the current method used to detect exogenous T administration.2 8
T and E exist in approximately equal amounts in men and women, with the
absolute quantities in women five-fold lower than men.29 The original T/E
ratio of 6:1 was evidence of using T, but many sport organizations had
reservations about implicating positive results because of the small number of
cases of T/E ratios greater than 6:1 that were not the result of exogenous T
abuse. 30 The recent lowering of the T/E ratio to 4:1 has led to more false-
positive tests due to several factors including individual, gender, and ethnic
differences. 31
a. Individual Differences
There have been cases of individual athletes whose T/E ratio naturally
exceeds 6:1.32 The most likely cause of abnormal T/E ratios is due to low
endogenous E production. 33 During the 1984 Olympic Games, a Japanese
volleyball player had a T/E ratio of 10:1, but was not suspended, and
investigations later validated that the athlete had a naturally elevated T/E
ratio. 34 Likewise, at the 1988 Seoul Olympics, a U.S. basketball player had a
T/E ratio of 7:1, but was exonerated because previous tests had demonstrated a
T/E ratio between 5.4:1 and 5.8:1. 35 There is no set percentage by which one
test must differ from another to be deemed suspicious; however, the ten
percent variation for the basketball player was determined to be too low to be
considered a positive test. 36
b. Ethnic Differences
Besides individual genetic differences in T and E levels, there is also
growing evidence that different ethnicities experience different T/E ratios.
Many East Asian athletes have a significantly lower T/E ratio than
27. Id.
28. Id.
29. Kammerer, supra note 2, at 11.
30. Id. at 12.
31. Handelsman & Heather, supra note 26, at 405.
32. Id.
33. Id.
34. Fitch, supra note 1, at 387.
35. Id.
36. Id.
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Caucasians. 37 Recent studies have identified a genetic deletion leading to a
functional mutation of a major hepatic androgenic enzyme that has a
significant influence on T/E ratios. 38  Compared with Caucasians, 39 the
genetic deletion of the enzyme occurs seven times more frequently in Asians
and five times less frequently in African Americans.4 ° As a result, many East
Asians have normal T/E ratios below 1:1.41 This means that they could use
exogenous T to increase their T levels by six to ten times and still register a
negative T/E ratio test result.
4 2
c. Gender Differences
It is more difficult to prove T doping by female athletes, because T levels
are much lower in females, and because both T and E levels can fluctuate. 43
This may be due to the monthly hormonal cycle-dependent fluctuations in the
T/E ratio or the use of oral contraceptives. 44 It is recommended that the T/E
ratio test be disregarded, especially in female athletes "because of the current
lack of scientific knowledge of natural variance limits of female androgen
production." 45
Alcohol use can also increase the T/E ratio for both genders, but this
increase is greater for women.46 A recent example of a high T/E ratio being
attributed to alcohol consumption is Floyd Landis. His T/E ratio after the
2006 Tour de France was 11:1,47 which Landis claimed was due to alcohol
use.
48
37. Id.
38. Jenny Jakobsson et al., Large Differences in Testosterone Excretion in Korean and Swedish
Men are Strongly Associated with a UDP-Glucuronosyl Transferase 2B17 Polymorphism, J. CLIN.
ENDOCRINOL & METAB. 687, 687-88 (2006).
39. Id. at 692.
40. Handelsman & Heather, supra note 26, at 405.
41. Fitch, supra note 1, at 387.
42. Id.
43. Kammerer, supra note 2, at 13.
44. Id. at 11.
45. David L. Black, Doping Control Testing Policies and Procedures: A Critique, in DOPING IN
ELITE SPORT: THE POLITICS OF DRUGS IN THE OLYMPIC MOVEMENT 29, 40 (Wayne Wilson &
Edward Derse eds., 2001).
46. Kammerer, supra note 2, at 13.
47. ASSAEL, supra note 25, at 270.
48. Juliet Macur & Gina Kolata, Landis is on Message, but Points are Disputed, N.Y. TIMES,
July 29, 2006, available at http://www.nytimes.com/2006/07/29/sports/othersports/29testing.html?
pagewanted=2&sq=landis%20and%20alcohol&st=nyt&scp= 1.
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d. Administration of Epitestosterone with Testosterone
The use of the T/E ratio test has led some athletes to mask the use of
androgens by co-administering E with T to reduce the T/E ratio to acceptable
levels.49 In fact, it has been suggested that during the 1980s the East Germans
administered E to their athletes to reduce their T/E ratio to less than 6:1.50 E
is now banned as a masking agent, and in 2004, the World Anti-Doping
Agency (WADA) stated that corrected urinary concentrations of E greater than
two ng/ml are indicative of E administration. 5 1
e. Low Dose/Route ofAdministration
Another more simple, yet effective, way to abuse androgens without
detection is simply to use low to moderate amounts of T that do not raise the
T/E ratio significantly. This is one of the main reasons WADA, in 2005,
lowered the T/E ratio from 6:1 to 4:1.52 Due to individual, gender, and ethnic
differences, some athletes could theoretically take moderate to large doses of
T and still remain within acceptable limits. As mentioned previously, East
Asians (or others with genetic anomalies) with normal T/E ratios below 1:1
could increase their ratio six- to ten-fold and still may not exceed the T/E ratio
cut-off.5
3
Another method employed by athletes is to dose with low amounts of T
using skin patches and gels. 54 The patches are designed to release T in
varying levels over a twenty-four hour period. 55 The low dose per patch,
along with time-release properties, yields more stable blood levels, making it
less likely for urinary testing to exceed a 6:1 T/E ratio.56 - With dose
modification combined with sustained-release application, it is possible for the
athlete to use T during training and even up to the competition with a very low
risk of testing positive. 57
49. Handelsman & Heather, supra note 26, at 405.
50. Fitch, supra note 1, at 387.
51. World Anti-Doping Agency, Minimum Required Performance Limits for Detection of
Prohibited Substances, http://www.wada-ama.org/rtecontent/document/perf limits_2.pdf (last visited
Aug. 7, 2008).
52. Fitch, supra note 1, at 387.
53. Id.
54. Krammerer, supra note 2, at 13.
55. WILLIAM LLEWELLYN, ANABOLICS 134 (2007).
56. Kammerer, supra note 2, at 13.
57. Id. at 13-14.
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2. Dihydrotestosterone
Dihydrotestosterone (DHT) is the most potent androgen in the human
body, measured to be approximately three to four times stronger than T. 58 T
is converted to DHT in the body via interaction with the 5-alpha reductase
enzyme.59 DHT is present in large amounts in tissues such as the prostate,
skin, scalp, liver, and various regions of the central nervous system (CNS).
It is the role that DHT plays in the CNS and muscular system, collectively
referred to as the neuromuscular system, which makes this drug attractive to
athletes. One study demonstrated increased androgen receptor proliferation in
neural cells in both T and DHT, with DHT sustaining the increase three times
as long.60 What this means in real world athletic competition is that an
increase in neuromuscular coordination could increase strength, power, and
reflex time.
In a classic study by Ariel and Saville,61 there was a demonstrable
increase in knee jerk reflex reaction time in athletes using AAS. 62 "These
data suggest that anabolic steroids might be beneficial for athletes such as
boxers, hockey goalies, and baseball hitters." 63 These results suggest that
potent androgens like DHT could benefit athletes whose sport demands quick
reaction time and short bursts of power and quickness.
DHT has been detected in athletes, including a number of female Chinese
swimmers at the World Championships in 1994.64 Positives were determined
by comparison analysis of DHT and other endogenous steroids. 65 DHT can,
therefore, be tested for along with a co-secreted precursor steroid, such as E.
The increase in the DHT/E ratio in urine can be an indicator of exogenous
administration of DHT. 66 However, as with the T/E ratio test, the individual,
ethnic, gender, and dose-response relationships that may make it difficult to
detect doping in some athletes.
58. LLEWELLYN, supra note 55, at 128.
59. Id.
60. Id.
61. Gideon Ariel & William Saville, Effect of Anabolic Steroids on Reflex Components, 32 J.
APPL. PHYSIOL. 795, 797 (1972).
62. Id. at 797.
63. REENTS, supra note 21, at 174.
64. Kammerer, supra note 2, at 13.
65. Id.
66. Handelsman & Heather, supra note 26, at 405.
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3. Designer Androgens
Designer androgens are "synthetic androgens purposely developed to
evade detection by the conventional urine MS-based doping tests." 67 Much of
the original research on designer androgens date back to the original AAS
developmental research in the 1960s and 1970s, when pharmaceutical
companies were experimenting with chemical variations of AAS. 68 When the
patent rights expired years later, some of these unique, chemically obscure
AAS remerged. 69
The AAS furazabol, from Japan, is a DHT derivative that was used by
athletes for several years before it was identified and tested for. 70 In 2002,
Don Catlin, "America's Leading Steroid Hunter," 71 detected an old designer
androgen called norbolethone in the urine of a female cyclist. 72 In 2003,
tetrahydrogesterinone (THG), a completely unknown androgen, was sent to
Catlin for analysis. 73 THG is the notorious designer androgen that arose from
the Bay Area Laboratory Cooperative (BALCO) scandal involving track star
Marion Jones. 74 In 2005, a third designer androgen,
desoxymethyltestosterone (DMT), was discovered. 75  Subsequently, other
designer androgens arose from the neutriceutical food supplements, which
advertised "prohormones" or androgen precursors. 76
The biggest problem associated with androgen doping is the sheer
diversity and almost infinite structural modifications that can be made, which
makes detection of these unknown androgens difficult. Detection methods,
such as GC-MS and LC-MS, use reference samples of the drug to compare
with the metabolites found in the urine. 77 Since the designer androgen is
unknown and there are no reference samples, athletes have the ability to use
designer androgens without detection.
67. Id.
68. Id.
69. Id. at 406.
70. LLEWELLYN, supra note 55, at 275.
71. ASSAEL, supra note 25, at xiv; Don Catlin was the Director of the UCLA Olympic Analysis
Laboratory from 1983-2007.
72. Fitch, supra note 1, at 388.
73. Id.
74. ASSAEL, supra note 25, at 254.
75. Handelsman & Heather, supra note 26, at 406.
76. Id.
77. Kammerer, supra note 2, at 9.
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4. DHEA and Prohormones
Starting in 1994, legislation allowed the sale of steroid precursors (i.e.
prohormones) as neutricuetical food supplements. 7 8  Soon thereafter, the
supplement companies started flooding the market with androgen precursors
or prohormones, such as 1-testosterone, dehydroepiandrosterone (DHEA), and
androstenendione. 79 At the time, there were neither testing nor bans by most
athletic associations on many of these new androgens. 80
Androstenendione, or "andro" as it was popularized, was the prohormone
that experienced a rapid growth in sales after Mark McGwire admitted using it
during his record-breaking home run season. 8 1  It was later reported that
"andro" acts similarly to AAS in the body and, in sufficient quantities, could
increase serum T levels and increase muscle mass in eugonadal males. 82
Meeting all the requirements as an AAS, Congress amended the earlier ruling
with new legislation that reclassified certain synthetic androgens as drugs
rather than food supplements. 83
DHEA is a weak androgen precursor that is converted in the peripheral
tissues to T and estradoil and functions as a neurosteroid. 84 The IOC prohibits
the use of DHEA. 85 The literature reveals that it is difficult to demonstrate
DHEA as being an ergogenic aid because of research limitations including
animal models, heterogeneity of dosing, formulations, and study populations
in humans. 86 It is difficult to test for DHEA using IRMS, the method of
choice. The complexity and genetic differences in metabolism may make it
difficult to differentiate between dietary and pharmaceutical DHEA. 87 DHEA
is detected with GC-MS by observing elevated DHEA hormone derivatives in
urine.8 8 However, detection is further complicated due to an incomplete
understanding of DHEA metabolism and natural variations in individual
78. Handelsman & Heather, supra note 26, at 406.
79. Id.
80. Id.
81. Karen Choong et al., The Physiological and Pharmacological Basis for the Ergogenic Effects
of Androgens in Elite Sports, 10 ASIAN J. ANDROL. 351, 357 (2008).
82. Id.
83. Handelsman & Heather, supra note 26, at 406.
84. Choong et al, supra note 81, at 358.
85. World Anti-Doping Code, The 2008 Prohibited List: International Standard, §S l(l)(b), Sept.
22, 2007, http://www.wada-ama.org/rtecontent/document/2008 List En.pdf (last visited Aug. 6,
2008).
86. Id.
87. Kammerer, supra note 2, at 11.
88. A.T. Cawley et al., Searching for New Markers of Endogenous Steroid Administration in
Athletes: "'Looking Outside the Metabolic Box", 143 FoRENsIc Sci. INT'L 103, 104 (2004).
[Vol. 19:1
THE BODY AND THE LAW
urinary excretions. 8
9
5. Gonadotropins and Indirect Androgen Doping
Another way athletes have tried to circumvent the ban on androgen doping
is to increase endogenous T indirectly with the use of gonadotropin drugs,
such as leutinizing hormone (LH) and human chorionic gonadotropin
(hCG). 90 These drugs indirectly stimulate T through LH-dependent Leydig
cells. 9 1 hCG is actually produced in the placenta of the female body during
the early months of pregnancy and is used as a marker for pregnancy tests. 92
Male athletes use hCG because it can stimulate endogenous T production
without affecting the T/E ratio. 9 3 Male bodybuilders have used hCG for years
to stimulate endogenous T production following a cycle of AAS. 94
Male athletes with urine levels greater than specific values of hCG and LH
are in violation of doping. 95 Both hCG and LH are detected in urine by using
analysis of immunoassays of hormone specific antibodies. 96 Some of these
methods have limitations, so now GC-MS and LC-MS are being combined
through WADA sponsored research. 9
In female athletes, it seems that hCG has negligible effects on T levels.98
Testing for hCG in women may have other legal ramifications because it may
expose an unrecognized pregnancy and, thus, be an invasion of privacy. 9 9
6. Anti-estrogens and Aromatase inhibitors
Anti-estrogens and aromatase inhibitors (Al) are often used by athletes
who self-administer AAS to decrease the side effects associated with increased
estrogen levels caused by AAS use.10 0 Tamoxifin citrate is a potent estrogen
antagonist in breast tissue and is used by male athletes to prevent breast tissue
89. Id.
90. Handelsman & Heather, supra note 26, at 409.
91. Id.
92. LLEWELLYN, supra note 55, at 551.
93. Osquel Barroso et al., Honnone Abuse in Sports: The Antidoping Perspective, 10 ASIAN J.
ANDROL. 391, 393 (2008).
94. LLEWELLYN, supra note 55, at 552.
95. Barroso et al., supra note 93, at 393.
96. Id.
97. Id. at 393-94.
98. Id. at 393.
99. ld.
100. LLEWELLYN, supra note 55, at 35.
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formation (i.e. gynocomastia) while using AAS.101 Tamoxifin citrate and
other anti-estrogen drugs, such as clomiphene, can increase the production of
follicle stimulating hormones (FSH) and LH in the male body. 10 2 Like the
gonadotropin drugs, the higher release of LH can stimulate the Leydig cells to
produce more T and, thus, increase athletic performance.
Anti-estrogens (e.g., tamoxifin citrate) are detected using LC-MS and GC-
MS; while, WADA has sponsored methods such as Liquid Chromatography-
tandem Mass Spectrometry (LC-MS/MS) and GC-MS to detect AIs such as
anastrozole and letrozole. 103
C. /l2-agonists
32-agonists are drugs that are clinically used in the treatment of asthma
and exercise-induced bronchoconstriction (EIB).10 4 One popular 132-agonist
used by athletes is albuterol, which is most commonly available as an
inhaler. 105 Evidence suggests that the route of administration of 132-agonists
influences the degree of metabolic effects. 106 Clinical data indicates that
albuterol, especially when administered via inhalation, provides no ergogenic
effect. 10 7 This has not stopped endurance athletes from taking "hits" from
their albuterol inhalers during triathlon competitions. 108
An interesting aspect of some longer lasting oral 132-agonists is their
influence on the musculoskeletal system. Clenbuterol, a long-acting 32-
agonist, which is available for human use in Europe, has demonstrated
anabolic effects in animal studies. 10 9 Clenbuterol is often used in livestock
animals to increase muscle mass and decrease fat mass. "10 Human studies on
clenbuterol are inconclusive because it is difficult to replicate the extremely
large doses used in animal studies. 1  Nevertheless, athletes believe
clenbuterol has muscle-building and fat-immobilizing effects. 112 Although its
101. Id. at 438.
102. Id.
103. Barroso et al., supra note 93, at 398.
104. REENTS, supra note 21, at 121.
105. Id. at 121-22.
106. Id. at 130.
107. Id. at 134.
108. See id.
109. LLEWELLYN, supra note 55, at 472.
110. REENTS, supra note 21, at 130.
111. Id.
112. Id.
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anabolic effects are questionable, the IOC bans clenbuterol. 113
Traditional screening and confirmation methods for clenbuterol doping in
humans are based on GC-MS. 114  However, newer testing procedures,
including improvements in LC-MS and LC-MS/MS, have been used because
of greater sensitivity and reduced sample preparation time.115  Confirmation
of doping 132-agonists, like clenbuterol, can be difficult because of the short
duration of the drug in the body. Clenbuterol has a half-life of approximately
thirty-four hours, making detection beyond several days, after discontinuing
ingestion, difficult.11 6 Since clenbuterol is used in small doses and can be
used during training up to several days before competition, use of this drug is
difficult to control.11 7 There is also a possible risk of a false positive test after
consuming meat from an animal that was administered clenbuterol. 118
D. Peptide Hormones
Non-steroidal peptide hormones with potential performance enhancing
properties are included on WADA's List of Prohibited Substances. 119 Banned
substances and their releasing factors include human growth hormone (hGH),
insulin-like growth factors (IGFs), insulins, erythropoietin (EPO), and
gonadotrophins (LH, hCG). 120
1. Human Growth Hormone & Insulin-Like Growth Factor 1
hGH is a protein hormone secreted from the anterior pituitary gland that is
important in the growth and anabolism of all body systems. 121 Levels of hGH
are particularly high in adolescence, when it promotes growth of muscles and
decreases levels of subcutaneous fat stores.122 Recombinant hGH (rhGH) is a
potent anabolic hormone when used to treat hormone deficient individuals, but
current research has demonstrated no statistically significant increases in
113. Kammerer, supra note 2, at 7.
114. Mario Thevis et al., Liquid ChromatographylElectrospray Ionization Tandem Mass
Spectrometric Screening and Confirmation Methods for fl2-agonists in Human or Equine Urine, 38 J.
MASS SPECTROMETRY 1197, 1197 (2003).
115. Id.
116. LLEWELLYN, supra note 55, at 60.
117. Kammerer, supra note 2, at 16.
118. Id. at 18.
119. World Anti-Doping Code, supra note 85, § S2.
120. Barroso et al., supra note 93, at 393. Due to gonadotrophins increasing T levels, they were
discussed under Androgens.
121. REENTS, supra note 21, at 150.
122. LLEWELLYN, supra note 55, at 501.
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muscle size or strength with administration. 123 Nevertheless, use of hGH is on
the rise with reports of athletes spending up to $30,000 per year on hGH. 124
In spite of its high cost, lack of proven effectiveness, and side effects,
athletes continue to abuse hGH because it is the most difficult drug to detect
using established drug testing procedures. 125 Developing a test for hGH is
challenging because urine concentrations are very low, there are variable
blood levels within the same individual throughout the day, and rhGH has the
identical amino acid sequence as endogenous hGH. 126 hGH has a half-life of
only fifteen to twenty minutes, and exogenous hGH administration dissipates
rapidly from the blood and urine. 127 hGH plasma concentrations can increase
up to ten-fold during exercise, therefore, increases in circulating hGH are not
indicative of exogenous use. 128 Due to these disadvantages, blood testing is
required to identify the abuse of hGH. 129 When hGH is secreted by the
pituitary gland, it circulates as a number of slightly different peptides called
isoforms. 130 One isoform, 22K GH, is the most abundant form of hGH and is
used in a ratio with other pituitary isoforms of hGH. 13 1
This "isoform approach" to testing hGH is very similar in nature to the
T/E ratio test for androgens. One major limitation of this test is the short
window (twenty-four to forty-eight hours post injection) of opportunity to
detect hGH. 132 The isoform test can only detect 22K GH, and if cannot detect
doping of pituitary-derived hGH, IGF-1, or hGH secretagogues.133 Although
the isoform method test was implemented by WADA during the 2004 Athens
and 2006 Turino Olympic Games, there have been no irregular findings using
this test. 134 This test may be useful for surprise random testing during out-of-
competition testing. 135
The other current approach of testing hGH doping is measuring hGH-
responsive proteins that have a longer half-life and more stable concentration
123. Graham et al., supra note 16, at 521.
124. REENTS, supra note 21, at 151.
125. Graham et al., supra note 16, at 521.
126. Anne E. Nelson & Ken K. Ho, A Robust Test for Growth Hormone Doping - Present Status
and Future Prospects, 10 ASIAN J. ANDROL. 416, 417 (2008).
127. Id.
128. Id.
129. Graham et al., supra note 16, at 521.
130. Nelson & Ho, supra note 126, at 417-18.
131. Id. at 418.
132. Patrick Arnold, EPO Wannabes and the Doping Wars, MUSCULAR DEV., July 2008, at 320.
133. Nelson & Ho, supra note 126, at 419.
134. Id.
135. Id.
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levels than hGH. 136  For example, hGH stimulates IGF-1, which is most
directly responsible for the anabolic actions of hGH. 137 Most of the IGF- 1 in
circulation is bound as a protein (IGFBP-3) that has a half-life of up to fifteen
hours. 138 hGH can also stimulate collagen peptides, which have a half-life of
ninety to five hundred hours, making these markers easier to detect. 139
One of the disadvantages of the hGH-responsive markers test is that there
may be a wide variation in hGH responsive proteins such as IGF-1.1 40 This
test is claiming an eighty-six percent chance of success in males and a sixty
percent chance in females using super-physiologic doses of hGH. I4' Despite
these drawbacks, the hGH markers approach could be improved by taking age
into account, using a combination of markers, and tracking within-subject
variability over time. There is also the advantage of detecting other agents
such as pituitary-derived hGH, IGF-1, or hGH secretagogues. 142
There are several new approaches being developed to detect hGH doping.
One novel approach is the study of gene expression in blood leucocytes. 143
There is strong evidence that hGH regulates the immune system, and
leucocytes respond directly to hGH and IGF-1.144 Another method,
proteomics, is being applied to blood serum to investigate protein markers or
diagnostic profiles from subjects treated with hGH. 145  Finally, new
immunoassay testing methods, along with older testing methods, such as mass
spectrometry tests, are being used to detect hGH doping. 146
Most of the growth effects, including increase in total body protein and
muscle synthesis with hGH, are mediated by IGF-1.1 47 hGH stimulates the
liver to produce IGF-1, which circulates and acts on body tissues.148
Experiments in mice using a gene delivery device produced an increase in
muscle mass and strength without affecting IGF-1 serum concentrations. 149
Due to this, athletes are experimenting with IGF-1 as an ergogenic aid.
136. Id. at 418.
137. Id.
138. Arnold, supra note 132, at 320.
139. Nelson & Ho, supra note 126, at 418.
140. Arnold, supra note 132, at 320.
141. Graham et al., supra note 16, at 521.
142. Nelson & Ho, supra note 126, at 422.
143. Id.
144. Id. at 422-23.
145. Id. at 423.
146. Id.
147. Barroso et al., supra note 93, at 394.
148. Id.
149. Id.
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2. Insulin
Insulin is a hormone secreted by the pancreas, which controls the uptake,
utilization, and storage of glucose, amino acids, and fatty acids by various
cells of the body. 150 Insulin-deficient patients suffering from Type- 1 diabetes
are the primary users of exogenous insulin. 151 Use of insulin by athletes is a
"very risky endeavor" because it can cause a variety of side effects, such as
hypoglycemia, the result of which can be coma or death. 152  Despite this,
athletes use insulin because of its potential performance enhancing effects.
Insulin can increase the rate of glucose uptake in muscle tissue, thus
promoting an anabolic effect and improving exercise recovery. 153
The detection of insulin in both the urine and blood presents significant
challenges. Hemolysis and/or anti-insulin antibodies can interfere with an
accurate blood analysis of insulin. 154 Classic methods of determining insulin
doping in urine samples using RIA have been difficult to confirm due to
problems differentiating synthetic and endogenous insulin. 155 WADA has
recently supported a new analytical method using LC-MS for the identification
of synthetic insulin in urine. 156
3. Erythropoietin
Erythropoietin (EPO) "is a glycoprotein hormone that is mainly produced
by the kidney and is a key regulator of red blood cell [(RBC)] production."' 157
Synthetic EPO was approved for human use in 1989 for treating anemia. 158
Athletes use EPO in hopes of increasing their blood's oxygen-carrying
capacity and, in turn, improve endurance and athletic performance. 159 EPO
use has a storied history, with the first suspected cases in cycling deaths in the
1980s. 160  Since then, EPO doping by elite athletes has made frequent
headlines. 161
150. LLEWELLYN, supra note 55, at 518.
151. Barroso et al., supra note 93, at 397.
152. LLEWELLYN, supra note 55, at 518, 520.
153. Barroso et al., supra note 93, at 397.
154. Id.
155. Id. at 397-98.
156. Id. at 398.
157. Id. at 396.
158. REENTS, supra note 21, at 204.
159. Id.
160. Barroso et al., supra note 93, at 396.
161. ASSAEL, supra note 25, at 159, 188.
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Methods for detecting use of synthetic EPO include a combination of
direct and indirect approaches.1 62 The direct method is based on differences
between the pattern and extent of glycosylation (glucose residues) in
exogenous EPO compared to endogenous EPO. 163 The indirect method
measures changes in hematological parameters of red blood cell production. 164
There are different testing procedures for the indirect method that can detect
EPO use from forty-eight hours post-injection up to two weeks after EPO
withdrawal. 165 During the 2000 Olympics, a combination of direct and
indirect methods were implemented to detect EPO in blood samples, but since
2004, only the direct, urine-based method of EPO testing has been used. 166
WADA is currently sponsoring research efforts directed at improving the
indirect EPO method, as well as funding development of software that will
improve the interpretive results from the direct method. 167 WADA is also
searching for alternative analysis methods that may help detect EPO
doping. 168
E. Clinical Exemptions for the Use of Androgens by Athletes
In 1992, the IOC agreed to allow prohibited substances to be used for
legitimate medical purposes. 169 Known as the Therapeutic Use Exemption
(TUE), an athlete requires an expert medical assessment with a number of
conditions to be met. 170 For example, androgen deficiency is treated with T
and must be administered carefully, especially to strength athletes where
androgen use can have a significant advantage. 171
F. Future Trends
There are several new classes of hormone agonists, antagonists, and
modifiers currently in testing and production. Selective androgen modulators
(SARMs) act as agonists in the androgen receptor in muscle and bone with
minor effects on the other organs, thus avoiding the negative side effects
162. Barroso et al., supra note 93, at 396.
163. Id.
164. Id. at 397.
165. Id.
166. Id.
167. Id.
168. Id.
169. Fitch, supra note 1, at 389.
170. Id.
171. Id.
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associated with AAS. 17 2 WADA prohibited SARMs in sport starting January
1, 2008.173
Myostatin is a secreted protein in the body that plays a central role in
skeletal muscle growth.' 7 4 Inhibiting the myostatin gene will produce muscle
growth in both animals and humans. 175  Although years away from
production, myostatin inhibitors have the potential to become powerful doping
agents to athletes. WADA has included myostatin inhibitors on the Prohibited
List and is currently funding research for their detection. 176
The "athlete passport" was recently proposed as a future method of drug
testing that documents the biological profile of an individual athlete over
time. 177 By establishing baseline values, future tests could then be used to
detect abnormalities that differ from the baseline levels. "This approach
would eliminate the inter-individual variability observed in the population-
derived ranges currently used." 178
The Union Cycliste Internationale (UCI) has adopted the "passport"
approach as part of its anti-doping program to curtail the use of EPO. 179 This
approach would have the potential to increase the sensitivity of testing
procedures such as the hGH-responsive marker approach. 180 Finally, it could
also be advantageous in the use of detecting natural androgens that rely on
ratio testing such as the T/E ratio test.
A potential problem with the "passport" approach involves young athletes.
Many sports, such as gymnastics, swimming, diving, and figure skating,
involve athletes much younger than eighteen. The youngest athletes
competing for the U.S. in the 2008 Olympic Games were fifteen years old. 181
At this age, humans are still going through natural growth and hormonal
changes. To establish a baseline using tests from these athletes would create
an inaccurate baseline. As a result, these baselines could be high or low,
allowing some athletes an advantage and putting others at a disadvantage in
future testing. The logical solution would be to not use the "passport" on
athletes below a minimum age. However, it would be legally questionable to
172. Id.
173. World Anti-Doping Code, supra note 85, § 1(2).
174. Barroso et al., supra note 93, at 398.
175. Id.
176. Id. at 399.
177. Nelson & Ho, supra note 126, at 423.
178. Barroso et al., supra note 93, at 397.
179. Id.
180. Nelson & Ho, supra note 126, at 423.
181. Brian Cazeneuve, Meet Team USA, SPORTS ILLUSTRATED, July 28, 2008, at 80.
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have a doping policy that applied differently between one group of athletes
and another.
III. THE LEGAL BARRIERS
The legal barriers to accurate drug testing confound the myriad of
physiological obstacles that exist to create and sustain accurate drug testing.
Whether a test can be performed at all and whether that test is admissible in a
court of law are both of concern. Just because science has invented a method
for detecting an ergogenic aid does not mean that the test is lawful or that the
results of that test can be enforced.
A. Constitutional Concerns
The Fourth Amendment of the United States Constitution protects people
"against unreasonable searches and seizures" 182 and requires that lawful
searches have a warrant, which can be issued only "upon probable cause,
supported by [o]ath or affirmation, and.., describing the place to be searched,
and the persons or things to be seized." 183
Multiple cases have found that obtaining bodily fluids is a seizure that is
protected under the Fourth Amendment. In Skinner v. Railway Labor
Executives' Ass'n, 184 the United States Supreme Court concluded that urine
testing "intrudes upon expectations of privacy that society has long recognized
as reasonable."' 185 The Supreme Court has also held that a blood test "plainly
involves the broadly conceived reach of a search and seizure under the Fourth
Amendment." 186
However, constitutional protections only apply when either a government
entity or private organization acting in the government's place is carrying out
the search.' 87 They do not apply to searches and seizures conducted by
private parties, regardless of whether they are based on any degree of
suspicion or are simply arbitrary. ' 88 Whether the Fourth Amendment applies
to sport organizations may very well depend on the organization and the laws
that govern the organization.
182. U.S. CONST. amend. IV.
183. Id.
184. Skinner v. Ry. Labor Executives' Ass'n, 489 U.S. 602 (1989).
185. Id. at 617.
186. Schmerber v. California, 384 U.S. 757, 767 (1966).
187. Skinner, 489 U.S. at 613-14.
188. Id. at 614.
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1. State Actors v. Government Agents
There are two ways that a private party can be required to grant
constitutional protections to individuals: if the private party is determined to
be either a state actor or a government agent. Although the two are related, the
criteria that must be met are different for each. The tests for being a state actor
are more difficult to satisfy than those for being a government agent.
a. State Actor
Four different tests have been used to determine whether a private
organization is a state actor. 189 These tests are "(1) the public function test[,]
(2) the state compulsion test[,] (3) the close nexus or symbiotic relationship
test[,] and (4) the entwinement test." 190
i. Public Function Test
The Supreme Court created the public function test in Rendell-Baker v.
Kohn.191 The purpose of this test is to determine whether the function being
carried out by the private entity "has been 'traditionally the exclusive
prerogative of the State,"'" 92 with the emphasis on the word "exclusive."
Since both private groups and the government have traditionally carried out
many functions, this requirement that the function be exclusive to the
government limits the applicability of this test in many situations. 193
ii. State Compulsion Test
The state compulsion test examines whether the state "exercised coercive
power or... provided such significant encouragement, either overt or covert,
that the choice must in law be deemed to be that of the State,"' 94 not of the
private party. Thus, whether the private party is a state actor depends on a
totality of the elements involved. 195
189. Bradley T. French, Comment, Charter Schools: Are For-Profit Companies Contracting for
State Actor Status?, 83 U. DET. MERCY L. REv. 251,263 (2006).
190. Id.
191. Rendell-Baker v. Kohn, 457 U.S. 830, 842 (1982).
192. French, supra note 189, at 263 (quoting Rendell-Baker, 457 U.S. at 842).
193. Id.
194. Blum v. Yaretsky, 457 U.S. 991, 1004 (1982).
195. French, supra note 189, at 264.
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iii. Entwinement Test
The entwinement test is a newer test, developed in Brentwood Academy v.
Tennessee Secondary School Athletic Ass 'n. 196 This test determines a private
party to be a state actor when the "nominally private character of the
[a]ssociation is overborne by the pervasive entwinement of public institutions
and public officials in its composition and workings, and there is no
substantial reason to claim unfairness in applying constitutional standards to
it." 197
iv. Close Nexus or Symbiotic Relationship Test
The close nexus or symbiotic relationship test is essentially an
amalgamation of the public function, state compulsion, and entwinement tests.
It takes into consideration all components involved in these three tests to
determine whether the relationship between the state and the private "entity to
be regulated are so pervasive as to hold that the entity has functionally
'merged' with the state."' 198
b. Government Agent
In determining whether a private party is an agent of the government,
courts use a more subjective test that examines "the degree of the
Government's participation in the private party's activities." 199 Furthermore,
"[c]onstitutional provisions for the security of person and property are to be
liberally construed, and 'it is the duty of courts to be watchful for the
constitutional rights of the citizen, and against any stealthy encroachments
thereon.'"200
Federal laws that mandate that private organizations perform some action
that an organization may or may not perform without such a mandate,
especially those actions that involve protected interests and rights, make the
private organization into a government agent when performing the required
action. A law that is "intended to supersede 'any provision of a collective
bargaining agreement"' 20 1 and, thus, prevents a private organization from
creating its own rules and regulations, is indicative of government
196. Brentwood Acad. v. Tenn. Secondary Sch. Athletic Ass'n, 531 U.S. 288, 288-89 (2001).
197. Id. at 298.
198. French, supra note 189, at 265.
199. Skinner v. Ry. Labor Executives' Ass'n, 489 U.S. 602, 614 (1989).
200. Byars v. United States, 273 U.S. 28, 32 (1927) (citing Boyd v. United States, 116 U.S. 616,
635 (1886)).
201. Skinner, 489 U.S. at 615.
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encouragement, endorsement, and/or participation in the business of the
organization, thus subjecting the organization to the Fourth Amendment. 20 2
Thus, in order for a private organization to be considered a government
agent for some action, it needs only to be performing that action in place of the
government or at the government's direction.
2. Professional and Collegiate Sport
Professional sport leagues are generally considered to be private
organizations. They are composed of private individuals engaging in the
business, management, and execution of a professional sport, in which the
federal government has never been involved.
There is no case that states that professional sport leagues are anything
other than private entities. In fact, the Oakland Raiders, Inc. 203 case confirms
that courts view leagues as private entities, because the court considered the
law of private organizations as primary in that case and declined to involve
itself in the inner workings of the National Football League. 20 4  Thus,
professional sport leagues and teams in the United States do not have to abide
by constitutional protections and are free to perform whatever searches they
deem necessary, at anytime they choose (although restrictions may be placed
upon this through collective bargaining with a player's union that sets criteria
for drug testing). 20 5
However, as Congress examines whether to mandate drug testing in
professional sports, this freedom that teams and leagues have from
constitutional considerations may change. Once the government has mandated
that drug testing occur, how that testing is carried out becomes a constitutional
issue, as the leagues carrying out such testing will be acting as agents of the
government. 206
The government may want the names of those who test positive, want to
know what substances they tested positive for, and fine leagues that do not
202. Id. at 615-16.
203. Oakland Raiders, Inc. v. Nat'l Football League, 32 Cal. Rptr. 3d 266, 284 (Ct. App. 2005).
204. Id.
205. See generally David M. Wachutka, Collective Bargaining Agreements in Professional
Sports: The Proper Forum for Establishing Performance-Enhancing Drug Testing Policies, 8 PEPP.
DIsP. RESOL. L.J. 147, 165-66 (2007). Wachutka argues that collective bargaining is the preferred
method of creating drug policy in professional sport, because "it allows the parties to negotiate their
own rights" and "it eliminates ... constitutional issues that may arise if the policy is implemented
through other means." Id. at 165.
206. Lindsey J. Taylor, Congressional Attempts to "Strike Out" Steroids: Constitutional
Concerns About the Clean Sports Act, 49 ARIZ. L. REv. 961,965 (2007).
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comply with the federal drug testing laws. 20 7 All of these would be further
evidence that the federal government has become involved in the business of a
private organization and has turned that organization into a government
agent. 208
Collegiate sports are treated similarly to professional sport leagues. The
National Collegiate Athletic Association (NCAA) is considered to be a private
organization, 20 9 and thus, is not required to grant constitutional protections to
the student-athletes at its member schools. Legislation requiring drug testing
would affect the NCAA similarly to professional sport leagues, by making the
NCAA a state agent, unless such legislation specifically exempted the NCAA,
collegiate, or amateur sport organizations.
3. Olympic Sports
a. United States Olympic Committee
In San Francisco Arts & Athletics, Inc. v. United States Olympic
Committee,210 the Supreme Court affirmed the Ninth Circuit's conclusion that
the United States Olympic Committee (USOC) is not a state actor. The court
stated that:
The fact that Congress granted it a corporate charter does not
render the USOC a Government agent. All corporations act
under charters granted by a government, usually by a State.
They do not thereby lose their essentially private character.
Even extensive regulation by the government does not
transform the actions of the regulated entity into those of the
government. Nor is the fact that Congress has granted the
USOC exclusive use of the word "Olympic" dispositive. All
enforceable rights in trademarks are created by some
governmental act, usually pursuant to a statute or the common
law. The actions of the trademark owners nevertheless remain
207. Id.
208. See id. at 965-66.
209. See, e.g., NCAA v. Tarkanian,_ 488 U.S. 179, 197 (1998) (stating that the NCAA is private
actor that "enjoy[s] no governmental powers"); Hill v. NCAA, 865 P.2d 633, 641 (Cal. 1994) (stating
that "the NCAA as a private organization, comprised of American colleges and universities, and
democratically governed by its own membership"); Arlosoroff v. NCAA, 746 F.2d 1019, 1021 (4th
Cir. 1984) (stating that the NCAA is "a voluntary association of public and private institutions");
O'Halloran v. Univ. of Wash., 679 F. Supp. 997, 1001 (W.D. Wash. 1988), rev'don other grounds,
856 F.2d 1375 (9th Cir. 1988) (stating that the NCAA is private entity).
210. S.F. Arts & Athletics, Inc. v. U.S. Olympic Comm., 483 U.S. 522, 547-48 (1987).
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private. Moreover, the intent on the part of Congress to help
the USOC obtain funding does not change the analysis. The
Government may subsidize private entities without assuming
constitutional responsibility for their actions.
This Court also has found action to be governmental action
when the challenged entity performs functions that have been
"'traditionally the exclusive prerogative"' of the Federal
Government. Certainly the activities performed by the USOC
serve a national interest, as its objects and purposes of
incorporation indicate. The fact "[t]hat a private entity
performs a function which serves the public does not make its
acts [governmental] action." The Amateur Sports Act was
enacted "to correct the disorganization and the serious
factional disputes that seemed to plague amateur sports in the
United States." The Act merely authorized the USOC to
coordinate activities that always have been performed by
private entities. Neither the conduct nor the coordination of
amateur sports has been a traditional governmental
function.2 11
However, the court's rejection of the USOC as a state actor does not mean
that the USOC is not a government agent, because the standard for being a
state actor is higher. If the federal government were to pass legislation
requiring sport organizations to perform mandatory drug testing on its athletes,
and if that law were to apply to amateur and Olympic sports, then the USOC
would be made into a state actor, just as the professional leagues and the
NCAA would be. However, whether the USOC is already an agent of the
government, and thus, required to adhere to constitutional rights and
protections, is an open question.212
The USOC was created through federal legislation 213 and is specifically
stated to be "a federally chartered corporation." 214 Among the purposes for
the existence of the USOC are "to obtain for the United States ... the most
competent amateur representation possible in each event of the Olympic
Games, the Paralympic Games, and Pan-American Games" 215 and to preside
211. Id. at 543-45 (citations omitted).
212. See Hilary Joy Hatch, On Your Mark, Get Set, Stop! Drug-Testing Appeals in the
International Amateur Athletic Federation, 16 LOY. L.A. INT'L & COMP. L.J. 537, 564 n. 180 (1994).
213. Ted Stevens Olympic and Amateur Sports Act, 36 U.S.C. §§ 220501-220529 (1998).
214. Id. § 220502(a).
215. Id. § 220503(4).
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over "all matters pertaining to United States participation in [those games],
including representation of the United States in the games." 216
These purposes indicate that the USOC is the representative of the United
States government in the Olympic arena, and the Ted Stevens Act directly
states that "[t]he USOC may represent the United States as its national
Olympic committee in relations with the International Olympic Committee
and the Pan-American Sports Organization and as its national Paralympic
committee in relations with the International Paralympic Committee." 217
Other sections grant the USOC power in certifying national governing bodies
(NGBs) for each sport218 and overseeing other international competition by
American athletes. 219
All of these provisions appear to make the USOC an agent of the U.S.
government and, as such, obligated to grant constitutional protections.
However, until an athlete challenges the USOC's right to drug test without
reasonable suspicion or a warrant, and the USOC is found to be a government
agent, the USOC will continue to avoid the restrictions of the Constitution.
Unless the courts determine otherwise, or the federal government
mandates drug testing, professional, collegiate, and Olympic sport
organizations do not have any constitutional barriers to administering drug
tests to their athletes. However, the USOC does not actually administer drug
tests to its athletes; it only creates procedures and enforces penalties when
doping violations are discovered. The United States Anti-Doping Agency
(USADA) is the actual entity that administers drug tests to athletes involved in
Olympic sports and organizations.
b. United States Anti-Doping Agency
USADA was created to address "gross shortcomings" in the USOC's drug
testing program. 22 ° Prior to USADA, the USOC administered drug tests, but
each sport's NGB was left to discipline athletes for doping violations under
216. Id. § 220503(3)(A).
217. Id. § 220505(c)(2).
218. Id. § 220521.
219. Id. § 220505(c)(1).
220. Dionne L. Koller, Health Law Symposium: Does the Constitution Apply to the Actions of the
United States Anti-Doping Agency?, 50 ST. LOUIS U. L.J. 91, 105 (2005). This article provides a
thorough and detailed analysis of whether USADA would be deemed a state actor by a court and
concludes that, although there are specific circumstances where USADA's actions may be deemed as
acting on behalf of the state, in general, USADA is not a government entity and cannot be deemed a
state actor. The article makes no references to whether USADA could be considered a government
agent, however.
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the NGB's own procedures. 221
The result was a conflict of interest, where the entities that tested and
disciplined athletes for doping offenses were also the entities responsible for
the selection of national teams. 222 At that time, there was a general belief at
the international level that the USOC and its affiliated NGBs had protected
those participating in doping and even helped them cheat. 223 As a result of
this situation, Congress and the Office of National Drug Control Policy
(ONDCP) worked together to create USADA, with the support of the
USOC. 22 4
USADA is designated as a private, non-profit organization that
administers the United States's drug testing program via a contractual
agreement between itself and the USOC.225 USADA has the freedom to test:
a. Any athlete who is a member of a NGB;
b. Any athlete participating at a competition sanctioned by the
USOC or a NGB;
c. Any foreign athlete who is present in the United States; or
d. Any other athlete who has given his/her consent to testing by
USADA or who has submitted an out-of-competition testing
location form to USADA or an IF within the previous twelve
months and has not given his or her NGB and USADA written
notice of retirement;
e. Any athlete who has been named by the USOC or an NGB to
an international team or who is included in the USADA
Registered Testing Pool or is competing in a qualifying event
to represent the USOC or NGB in international competition;
f. Any United States athlete or foreign athlete present in the
United States who is serving a period of ineligibility on
account of an anti-doping rule violation and who has not
given prior written notice of retirement from all sanctioned
competition to the applicable NGB and USADA, or the
applicable foreign anti-doping agency or foreign sport
association. 226
221. Id. at 98.
222. Id.
223. Id. at 97.
224. Id. at 95-6, 106.
225. Id. at 108.
226. United States Anti-Doping Agency, Protocol for Olympic Movement Testing, 1-2, Aug. 13,
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As a result, USADA has the ability to test virtually all amateur and
professional athletes involved in an Olympic sport.
By being designated as a private entity, and not a government
organization, USADA is able to avoid granting constitutional protections to
the athletes it tests. 227 However, if USADA were designated as a state actor
or government agent, then it would have to abide by constitutional
limitations. 228 There are no cases stating that USADA is a state actor, so until
there is such a case, it will remain a private entity. Whether USADA could be
considered a government agent is a separate issue.
Arguments in support of USADA being a government agent include,
"Congress has designated USADA as the 'official anti-doping agency' for the
United States," 229 Congress has given USADA the exclusive right to perform
and sanction drug tests on all athletes, 230 the majority of USADA's operating
budget is received from the federal government, 2 31 and "USADA was created
to fulfill important government objectives, [and] the federal government has a
continuing interest in and influence over its operations." 232
Arguments that support the contention that USADA is not a government
agent include, USADA is not a government corporation, but is incorporated in
Colorado, 233 the U.S. government has never been directly involved in drug
testing and got involved with creating USADA only because the USOC's
program was ineffective, 234 and USADA's day-to-day activities are neither
overseen nor controlled by the federal government. 235
These arguments, however, only support the contention that USADA is
not a state actor. Since the requirements for being considered a state actor are
lower than those for being a government agent, failure to meet the state actor
test does not equate with failure to meet the government agent test.
There is little question that the USADA runs the United States's drug
testing program at the government's direction. The fact that the U.S. Congress
and ONDCP created USADA with the mandate that it is "the United States's
2004, available at http://videos.usoc.org/documentsnotices/protocol.pdf.
227. Koller, supra note 220, at 109.
228. Id.
229. Id. at 112.
230. Id. at 117.
231. Id. at 120.
232. Id. at 128.
233. Id. at 113.
234. Id. at 95-96, 106, 122.
235. Id. at 125.
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'official' anti-doping agency" 236 is evidence that USADA's existence and its
actions are at the direction of the government. Furthermore, the specific
actions that USADA takes are very similar to those that Congress expressed
should be taken by a national doping agency.
In October 1999, Senator John McCain stated that "[t]esting must be
universal in that all athletes wishing to compete in the Olympic games should
be required to submit to the testing regime established by this independent
agency... [and] a comprehensive and sustained anti-drug and sports ethics
education program should be developed and implemented. 237
Currently, USADA does test all athletes involved with Olympic sports,
both during and out of season, 238 and education focusing on the ethics of using
performance enhancing drugs is listed as one of USADA's four primary
focuses. 239 The fact that USADA has adopted Congress's goals for such an
organization is further evidence that USADA could be deemed a government
agent, acting in place of or at the government's direction. This would make
USADA subject to constitutional limitations.
4. Recent Development
On August 4, 2008, President George W. Bush signed the United Nations
Educational, Scientific and Cultural Organization's (UNESCO) International
Convention against Doping in Sport (the Convention). 240 The U.S. became
the ninetieth country to sign onto the Convention, 241 which states that its
purpose "is to promote the prevention of and the fight against doping in sport,
with a view to its elimination." 242
236. Id. at 122.
237. Id. at 105 (citing Effects of Performance Enhancing Drugs on the Health of Athletes and
Athletic Competition: Hearing Before the S. Comm. on Com., Sci., & Transp., 106th Cong. 23 (1999),
available at http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname= 106_senatehearings&
docid=f:75594.pdf).
238. United States Anti-Doping Agency, supra note 226, at 3-4.
239. USADA, USADA Mission, USANTIDOPING.ORG, June 8, 2008, http://www.usantidoping.
org/who/mission.html.
240. United Nations Educational, Scientific and Cultural Organization, United States Ratifies
International Convention against Doping in Sport, UNESCO.ORG, http://portal.unesco.org/en/ev.php-
URLID=43227&URL_
DO=DOTOPIC&URLSECTION=201.html (last visited Aug. 6, 2008) [hereinafter UNESCO].
This treaty was signed four days before the deadline for this article and a full analysis of its impact
and possible repercussions was simply not possible given the limited time available.
241. Id.
242. United Nations Educational, Scientific and Cultural Organization, International Convention
against Doping in Sport 2005, UNESCO.ORG, http://portal.unesco.org/en/ev.php-URLJD=31037&
URLDO=DOTOPIC&URLSECTION=201.html (last visited Aug. 6, 2008) [hereinafter ICADIS
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The Convention provides several means of achieving its purpose,
including that the nations who are party to the Convention "adopt appropriate
measures at the national and international levels, which are consistent with the
principles of the [WADA] Code." 24 3 The Convention further defines these
measures as including, but not limited to, "legislation, regulation[s], policies
or administrative practices." 244 Finally, it states that the signatory nations
"commit themselves to the principles of the [WADA] Code as the basis for the
measures provided for in Article 5."245
Given that the U.S. Senate approved ratification of the Convention on July
22, 2008,246 the Convention constitutes a treaty. A treaty is binding on the
states as "the supreme Law of the Land."'247 By agreeing to adopt WADC at a
national level, making it essentially the national law on doping, it appears that
the U.S. government has involved itself in drug testing and regulation
sufficiently to cause those entities and organizations that perform and enforce
drug testing on athletes to be deemed state actors.
Both the state compulsion and the close nexus tests can be met by the
existence of this treaty, and presumably, the subsequent legislation that will be
forthcoming. Once there is law regarding doping, it is obvious that the state is
compelling organizations to abide by specific standards, and it can be strongly
argued that the government has regulated doping so pervasively that those
organizations involved in doping control and testing could be deemed to be
"functionally 'merged' with the state." 248
As the repercussions of this treaty begin to manifest themselves, the
USOC, USADA, and perhaps even professional sports leagues and the NCAA
could find themselves to be state actors, obligated to grant their members and
employees constitutional protections.
B. The Admissibility of Scientific Evidence in Court
Simply because an entity has the right to administer a drug test and simply
because a test has been devised that detects some drug, does not mean that the
test given, if challenged in a court of law, will be admissible or valid.
Development by science does not guarantee acceptance by the law.
2005].
243. Id. art. 3(a).
244. Id. art. 5.
245. Id. art. 4(1).
246. ICADIS 2005, supra note 242.
247. U.S. CONST. art. VI, cl. 2.
248. French, supra note 189, at 265.
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1. Tests for Admissibility of Scientific Evidence
Several different tests are used to determine whether given scientific
evidence is admissible in court: 1) the relevancy standard; 2) the Frye or
general acceptance test; and 3) the Daubert test.
a. The Relevancy Standard
The main purpose of the relevancy test is to determine whether scientific
evidence is relevant to a given case. The relevancy test generally consists of
three basic questions: "(1) is it relevant; (2) is the witness a qualified expert;
and (3) will the evidence assist the trier of fact." 249
The primary purpose of this test is to determine whether the person
testifying about the scientific evidence is an expert.250  The underlying
scientific principles and procedures are admissible, and their credibility is
assessed based on the expert witness testimony and cross-examination. 251
b. The Frye Test
The Frye test is also known as the general acceptance test. 252  The
purpose is to determine whether the scientific evidence in question has been
"sufficiently established to have gained general acceptance in the particular
field in which it belongs." 253  Instead of relying on expert witnesses to
determine whether a scientific principle or process is admissible, the court has
the scientific community, as a whole, "determine if the proposed scientific
evidence has met with enough general acceptance so as to be reliable for use
in a court of law." 254  In order to determine whether proffered scientific
evidence has been generally accepted in the scientific community, courts
employ a test comprised of three prongs.
The first prong asks the general question of "whether there is a generally
accepted theory in the scientific community that supports the contention
proposed. ' 255 The second prong asks whether there are already generally
249. Michael A. Riley, How Should North Dakota Approach the Admissibility of DNA: A
Comprehensive Analysis of How Other Courts Approach the Admissibility of DNA, 72 N. D. L. REV.
607, 624 (1996) (citing State v. Peters, 534 N.W.2d 867, 872 (Wis. 1995)).
250. Id.
251. State v. Peters, 534 N.W.2d 867, 872 (Wis. 1995).
252. Riley, supra note 249, at 617.
253. Frye v. United States, 293 F. 1013, 1014 (D.C. Cir. 1923).
254. Riley, supra note 249, at 617.
255. Jeffery A. Norman, Comment, DNA Fingerprinting: Is It Ready for Trial?, 45 U. MIAMI L.
REV. 243,248(1990).
[Vol. 19:1
THE BODY AND THE LAW
accepted techniques capable of producing reliable results in the specific
scientific field at issue. 256 In the final prong, the court examines whether the
specific processes and procedures of the scientific method at issue were
followed properly in each individual case. 257
The purpose of the Frye test is to determine whether the science behind
specific evidence is valid, has been obtained in a reliable way, and is
supported by the scientific community.
c. The Daubert Test
The most recent of the tests for the admissibility of scientific evidence is
the Daubert test, established in Daubert v. Merrell Dow Pharmaceuticals,
Inc.258 This is the only test used in the federal courts because it supersedes
Frye. 259 Half a century after Frye was established, the Federal Rules of
Evidence were created. 260 Rule 702 of the Federal Rules of Evidence applies
to scientific evidence. 261  It states that "[i]f scientific, technical, or other
specialized knowledge will assist the trier of fact to understand the evidence or
to determine a fact in issue, a witness qualified as an expert by knowledge,
skill, experience, training, or education, may testify thereto in the form of an
opinion or otherwise." 262
The Court went on to further define and clarify Rule 702 by stating that
"'scientific' implies a grounding in the methods and procedures of science" 263
and that "'knowledge' connotes more than subjective belief or unsupported
speculation." 264 The purpose is to require "that an expert's testimony pertain
to 'scientific knowledge' establishes a standard of evidentiary reliability. 265
Finally, the Court concluded that whether evidence "will assist the trier or
fact" speaks to the relevance of the proffered evidence to the facts of the case
at hand. 266
With these parameters established, the Court created a four-part test to
determine the admissibility of scientific evidence: 1) whether it has been or
256. Id.
257. Id.
258. See generally Daubert v. Merrell Dow Pharm., Inc., 509 U.S. 579 (1993).
259. Riley, supra note 249, at 620.
260. Daubert, 509 U.S. at 587.
261. Riley, supra note 249, at 620.
262. FED. R. EVID. 702.
263. Daubert, 509 U.S. at 590.
264. Id.
265. Id.
266. Id. at 591.
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can be tested; 267 2) "whether the theory or technique has been subjected to
peer review and publication"; 268 3) what the rate of known error is; 269 and 4)
whether the technique or knowledge has been generally accepted in the
scientific community. 270  This test permits the court to examine the
methodology and reasoning behind the proffered evidence and determine
whether the evidence fits with the facts of the specific case before the court. 271
2. Applicability of Scientific Admissibility Tests to Doping Cases
Whether a specific drug test is admissible in a court of law as scientific
evidence of an athlete's doping would depend on which of the preceding tests
were applied to the case. In most cases, the Daubert test is the test that would
apply. This is because most of the sport organizations involved in drug testing
are interstate organizations.
The USOC's charter specifically states that:
[A]ny civil action brought in a State court against the
corporation [the USOC] and solely relating to the
corporation's responsibilities.., shall be removed, at the
request of the corporation, to the district court of the United
States in the district in which the action was brought, and such
district court shall have original jurisdiction over the action
without regard to the amount in controversy or citizenship of
the parties involved.272
To demonstrate the difference in admissibility between doping tests, the
Daubert test will be applied to both the hGH-responsive marker test and the
GC-MS test. Based on the following analyses, it would appear that the hGH-
responsive marker test does not meet the criteria for admissible scientific
evidence, whereas the GC-MS test does (and already has).
The first prong of the Daubert test, which inquires whether a substance
has been or can be tested, is met by the hGH-responsive marker test. The test
267. Id. at 593.
268. Id.
269. Id. at 594.
270. Id.
271. Riley, supra note 249, at 621.
272. 36 U.S.C. § 220505(b)(9). A search of LexisNexis with the only search parameter "United
States Olympic Committee" as a party in the case revealed sixty-four cases, fifty-two of which were
federal court decisions. The remaining twelve cases include three denials to hear by the Michigan
Supreme Court and four related to injuries while working or practicing, among others. Only one case
involves a positive drug test being appealed, although the accuracy of the drug test is not at issue. See
Walton-Floyd v. U.S. Olympic Comm., 965 S.W.2d 35 (Tex. App. 1998).
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definitely tests for something measurable, namely IGFBP-3 and collagen
peptides. 273
hGH-responsive marker testing has not been the subject of many peer-
reviewed publications. There are only a few articles that mention it, and most
of those articles speak of it as a future method of testing.274 Just two articles
could be found that actually applied the hGH-responsive marker test to a
clinical test, and the same researchers performed both of these tests. 275 At this
point, there is little published support for hGH-responsive marker testing.
The most difficult prong for the hGH-responsive marker test to satisfy is
the requirement regarding the rate of known error. The stated error rate of
fourteen percent for males and forty percent for females 276 is incredibly high.
Furthermore, the doses administered have to be significantly above natural
physiological amounts to register even these failure rates. 277 Presumably,
lower doses would have an even higher rate of inaccurate results.
Although there is no set rate of error that is required to satisfy a Daubert
test, and the rate of error should not be considered "a litmus test for
determining the admissibility of an expert's work," 278 a test that fails to
register an accurate positive test for almost half of the people tested cannot be
considered a reliable test. To determine whether the error rate of a given
scientific procedure is reasonable, the error rate can be compared against the
error rates of other procedures that serve the same purpose. 279 The error rate
of other tests used to detect doping by athletes include T/E ratio tests having
4% false positives and 46% false negatives, 280 and T/LH ratio tests having a
13% rate of false positives and 24% of false negatives. 281 A study of EPO
testing labs revealed that some labs failed to detect 100% of doping in athletes
273. Nelson & Ho, supra note 126, at 418; Arnold, supra note 132, at 320.
274. See, e.g., Nelson & Ho, supra note 126; Graham et al., supra note 16, at 520-2 1.
275. See generally, A. E. Nelson et al., Influence of Demographic Factors and Sport Type on
Growth Hormone-Responsive Markers in Elite Athletes, 91 J. CLINICAL ENDOCRIN. & METAB. 4424
(2006) [hereinafter Influence]; A. E. Nelson et al., Erythropoietin Administration Does Not Influence
the GH-IGF Axis or Makers of Bone Turnover in Recreational Athletes, 63 CLINICAL ENDOCRIN. 305
(2005) [hereinafter EPO Does Not Influence].
276. Graham et al., supra note 16, at 521.
277. Id.
278. Cook v. Rockwell tnt'l Corp., No. 90-cv-00181-JLK, 2006 U.S. Dist. LEXIS 89121, at *69
n. 25 (D. Colo. 2006).
279. In re TMI Litigation Cases Consolidated II, 911 F. Supp. 775, 802 (M.D. Pa. 1996).
280. Paul J. Perry et al., Detection of Anabolic Steroid Administration: Ratio of Urinary
Testosterone to Epitestosterone vs the Ratio of Urinary Testosterone to Luteinizing Hormone, 43
CLINICAL CHEM. 731, 731 (1997).
281. Id.
2008]
MARQUETTE SPORTS LA W REVIEW
who had been administered EPO. 282
Furthermore, tests using hGH-responsive marker testing have found there
to be variations in the results based on the age and gender of the athlete, and to
a lesser degree on their ethnicity. 283 Given that the consequences of failing
this test can be the loss of an athlete's sporting career, the failure rate is too
high to be deemed reliable scientific evidence.
When there are few scientific studies to support a testing method and few
authors have discussed the specific method, it is difficult to argue that the
scientific community has generally accepted the scientific procedure in
question. hGH-responsive marker testing does not yet have the clinical
research to support such acceptance.
Given that hGH-responsive marker testing can only meet the first prong of
the Daubert test at this time, all results from using this test would have to be
deemed inadmissible in a court of law. An athlete testing positive using this
method would have grounds to argue that the testing procedure is invalid and
unreliable.
In contrast, the GC-MS test meets all the criteria of the Daubert test. Like
the hGH-responsive marker approach, GC-MS does test something that is
measurable - the level of a certain drug, or drugs, in urinary excretions.
However, that is where the similarity to hGH-responsive marker testing
ends. GC-MS has been subjected to extensive trials and publications that
verify it as an accurate and reliable method of detecting drugs in urine.
Members of the medical community have described it as the 'gold standard'
in analytical chemistry."2 84 The U.S. Court of Appeals for the Seventh Circuit
stated that GC-MS is "probably the most accurate of the urinalysis tests;
surveys have rated it as nearly infallible." 285 Although this Seventh Circuit
decision predates Daubert by four years, the court's acceptance of GC-MS's
accuracy speaks to the test's ability to stand up to a Daubert challenge.
The success rate for GC-MS is "essentially 100%," and it has a minimum
scale error ratio. 286 This is because "each chemical has its own unique
fragmentation pattern [and thus], a properly performed GC-MS analysis has a
negligible likelihood of misidentifying a particular chemical. ' 287 The only
282. Carsten Lundby et al., Testing for Recombinant Human Erythropoietin in Urine: Problems
Associated with Current Anti Doping Testing, J. APPL. PHYSIOL. (forthcoming), available at
http://jap.physiology.org/cgi/reprint/90529.2008v1.
283. See generally, Influence, supra note 275.
284. Greenblatt, supra note 8, at 655.
285. Taylor v. O'Grady, 888 F.2d 1189, 1192 n.4 (7th Cir. 1989).
286. Greenblatt, supra note 8, at 655.
287. Id.
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way that a false positive can be registered is if two drugs have identical
retention times, and thus, appear to be the same substance. 2 88 However, the
likelihood of such an occurrence is remote. 289
Finally, the scientific community has generally accepted GC-MS. It was
first used to test for athlete doping during the 1976 Montreal Olympic
Games, 290 meaning that GC-MS is in its fourth decade as a testing method for
doping. The fact that GC-MS is the "gold standard" further supports its
acceptance by the members of the scientific community. 29 1
Most tests that will be admissible under Daubert will be those tests that
have stood the test of time. Only after repeated trial and publication is a test
deemed to be generally accepted. Although the older, established tests might
not be able to detect all drugs used for doping, those tests have a better chance
of withstanding legal challenges than new tests that may have only limited
research. By using tests that are valid in a court of law, those seeking to
enforce the test results need only prove that the test was performed properly in
the specific case at issue. This is a far easier challenge than proving the
reliability and accuracy of the testing method itself.
IV. CONCLUSION
Whether completely accurate drug testing can ever be achieved is a
serious question. With new drugs and detection methods being created
constantly, the legal community will have difficulty keeping up and will often
be behind the science. This lapse creates an opportunity for those who are
determined to cheat.
It also creates the risk that athletes will have their reputations, careers, and
livelihood ruined over drug test results that may not be based on the most
accurate and reliable science. Court challenges can take years, and even if a
player is exonerated because the testing method is invalid, the damage to their
career and reputation would have already been done. Although many in the
doping control field would have athletes, and the public, believe that testing is
accurate, reliable, and unchallengeable, there are some in their own arena that
disagree and are critical of the entire anti-doping system.
Donald A. Berry, a biostatistician and head of the Division of Quantitative
Sciences at Texas's MD Anderson Cancer Center, argues that the anti-doping
288. Id. at 656.
289. Id.
290. Kammerer, supra note 2, at 4.
291. See Greenblatt, supra note 8, at 655.
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sciences are "weak" and "something [he] regards not to be science." 292 He
also contends that operating characteristics such as lab, sample handling, and
interpretation errors, as well as machine malfunctions, make it difficult to
know the true accuracy of drug testing. 293
Berry is especially concerned about new testing procedures that test
natural hormones, such as EPO and hGH, arguing that rigorous statistical
research is required when using large population samples under similar
competition-like conditions. 294 Matthew Slawson, director of the University
of Utah Sports Medicine and Research Testing Laboratory, a WADA-
approved lab, said that such large-scale testing "would be useful and very
valuable, but very expensive." 295  Berry dismisses financial and other
objections by putting it bluntly:
If we cannot as a society afford to fund that sort of effort, then
we ought not to be trying to make these measurements and
ruin people's lives.... If we want to do it, then we have to do
it right. Doing it in a half-assed way is not serving
anybody. 296
292. Brian Alexander, Shaky Science Casts Doubt on Doping Results: As Olympics Begin,
Researcher says Testing System is Critically Flawed, MSNBC.COM, Aug. 6, 2008, http://www.
msnbc.msn.com/id/26045416/.
293. Id.
294. Id.
295. Id.
296. Id.
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